Pricing Log in Create free account
Saturday 17 October 2026 Export ZBH’s income statement to Excel — free account

Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Zimmer Biomet Holdings, Inc. (ZBH) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a P/S ratio of 2.1×. Over the past ten years it has ranged from 1.8× (May 2026) to 6.1× (April 2021); the current reading is higher than 4% of that period. That is below the Medical Devices industry median of 2.3× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.2× (22.58%)
FY2024 2.8× (18.45%)
FY2023 3.4× (10.87%)
FY2022 3.8× 2.01%
FY2021 3.8× (25.43%)
FY2020 5.1× 35.35%
FY2019 3.7× 44.55%
FY2018 2.6× (17.11%)
FY2017 3.1× 19.11%
FY2016 2.6× (15.92%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 1.9× (7.26%)
Mar 2026 2.1× (3.06%)
Dec 2025 2.2× (11.20%)
Sep 2025 2.4× 5.71%
42 more quarters

Against its own ten years

Low 1.8× High 6.1×
Ten-year median 3.2×
Current reading's percentile 5

P/S ratio against peers

Company P/S ratio
PHG Koninklijke Philips N.V. compare 1.2×
SNN Smith & Nephew SNATS, Inc. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.5×
ZBH Zimmer Biomet Holdings, Inc. 2.1×
GMED Globus Medical, Inc. compare 3.3×
STE STERIS plc compare 3.6×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
DXCM DexCom, Inc. compare 6.6×
PEN Penumbra, Inc. compare 8.4×
Medical Devices industry median 2.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on ZBH